INTRODUCTION {#sec1-1}
============

Because infertility are highly diversified in etiology, their treatments also require diversified approach. Some orthodox medications and traditional medications have proved really useful in the treatment of infertility.\[[@CIT1]\] However, orthodox medications often have the disadvantage of strong side effects and too high costs.\[[@CIT2]\]

Some traditional doctors claim to use ethanolic extract of *Sesamum indicum* (EES) and citrus fruits \[sources of vitamin C (VC)\] to promote fertility. If we could establish that EES in conjunction with VC significantly promotes fertility, then there is a possibility that some cases of infertility could be treated cheaply with EES and VC. Many studies have also shown that antioxidants can enhance fertility either directly or indirectly and that most plants rich in antioxidants have the tendency to increase sperm counts, motility, and enhance sperm morphology.\[[@CIT3][@CIT4]\] *Sesamum indicum* has lots of components appropriate for detoxification and quite a number of antioxidants such as sesamol, sesamolin sesamin, butylated hydroxytoluene, sesaminol triglucoside, and sesaminol diglucoside.\[[@CIT5]\] Similarly VC has been shown to be a free radical scavenger and to protect against lipid peroxidation. This ability has been reported to increase peripheral testosterone level and also attenuate testicular toxicity.\[[@CIT6]\] There is, therefore, a high possibility that EES acting alone, or with VC, can promote fertility and/or treat infertility.

This study aims to investigate the efficacy of EES, VC, and EES + VC in promoting fertility, and find a possible link between their profertility effects and antioxidant activities.

MATERIALS AND METHODS {#sec1-2}
=====================

Forty adult male Wistar rats of average body weight 186.56 ± 0.465 g were used for this study. They were inbred in the Animal House of the Faculty of Basic Medical Sciences, Ladoke Akintola University of Technology, Ogbomoso, Nigeria. The animals were transferred to the research section, and acclimatized over a period of 2 weeks. The research section was adequately ventilated and maintained at a temperature of 24-26°C, relative humidity of 70-75%, and at light/dark cycle of 12/12 hours. The rats were fed with commercially available rat pellet. The maintenance, care, and treatments of the rats comply with National Institutes of Health guidelines for the humane use of laboratory animals, and those of Ladoke Akintola University of Technology, Ogbomoso, Nigeria.

The VC used was manufactured by, and obtained from, Tuyil Pharmaceutical Company, Ilorin, Nigeria. *Sesamum indicum* was obtained from Forest Research Institute of Nigeria (FRIN), Ibadan, Nigeria. The *Sesamum indicum* was authenticated in the Herbarium Unit of the Department of Pure and Applied Biology, Ladoke Akintola University of Technology, Ogbomoso, Nigeria, and assigned Specimen number S11387.

EES was prepared following the exact method described by Kizhiyedathu *et al*.\[[@CIT5]\]

Grouping of animals and treatment {#sec2-1}
---------------------------------

The rats \[average body weight (BW) 186.56 ± 0.465 g\] were randomly analyzed into four groups of 10 rats each: Control, EES~G~ (extract of *Sesamum indicum* only), VC~G~ (vitamin C only), and EES + VC~G~ (EES indicum in conjunction with VC). Control was given 5 ml/kg BW of normal saline orally per day; EES~G~ was administered 0.3 g/kg BW of EES per day; VC~G~ was administered 15 mg/kg BW of VC per day; while EES + VC~G~ was administered both 0.3 g/kg BW of EES and 15 mg/kg BW of VC per day. All treatments were for 10 weeks.

Animal sacrifice and collection of samples {#sec2-2}
------------------------------------------

Twenty-four hours after the last treatment, each animal was weighed and then sacrificed by cervical dislocation. Up to 4.0 ml blood samples were collected via cardiac puncture. Blood sample obtained from each rat was divided into two portions: 2.0 ml in a plain bottle and the other 2.0 ml in an ethylenediaminetetraacetic acid bottle. Plasma and serum were obtained by centrifugation at 3000 rpm for 20 minutes. Testis and caudal epididymis were excised from each rat.

Collection of data and statistical analysis {#sec2-3}
-------------------------------------------

The left testis of each rat was homogenized (using soft tissue homogenizer manufactured by Omni International, USA) for tissue superoxide dismutase (SOD) and catalase (CAT) activities, and malondialdehyde (MDA) concentration. Sperm count, motility, morphology, and life-death ratio of the rats\' spermatozoa were carried out from the epididymis. Serum testosterone level was determined. Plasma and tissue SOD and CAT activities, and MDA concentrations were determined using the methods described by Fridovich,\[[@CIT7]\] Sinha,\[[@CIT8]\] and Varshney and Kale,\[[@CIT9]\] respectively.

The data obtained are presented as mean ± SD. The control and test groups were compared using Independent-sample T test. Significance level was taken at *P*-value \<0.05.

RESULTS {#sec1-3}
=======

Body weight and testicular weight {#sec2-4}
---------------------------------

Comparing their final and initial weights showed that there was significant body weight gain in all the groups over the period of the experiment. The weight gain in EES~G~ group as well as EES + VC~G~ was, however, significantly (*P*-value \<0.01) higher than that of the control, while weight increase in VC~G~ showed no significant difference from that of the control \[[Table 1](#T0001){ref-type="table"}\].

###### 

Body weight and testicular weight

                                Control         EES~G~                                             VC~G~           EES + VC~G~
  ----------------------------- --------------- -------------------------------------------------- --------------- ---------------------------------------------------
  Weight before sacrifice (g)   202.6 ± 0.290   211.5 ± 0.365                                      205.3 ± 0.329   212.6 ± 0.346
  Initial weight (g)            185.9 ± 0.257   186.1 ± 0.291                                      187.6 ± 0.299   186.3 ± 0.333
  Weight increase (g)           16.7 ± 0.238    25.4 ± 0.289[\*\*](#T000F2){ref-type="table-fn"}   17.7 ± 0.252    26.3 ± 0.311[\*\*](#T000F2){ref-type="table-fn"}
  Testicular weight (g)         0.660 ± 0.033   0.714 ± 0.029[\*](#T000F1){ref-type="table-fn"}    0.624 ± 0.024   0.746 ± 0.032[\*\*](#T000F2){ref-type="table-fn"}

*P*-value \< 0.05

*P*-value \< 0.01

The testicular weight of VC~G~ showed no significant (*P*-value \>0.05) difference from that of the control, while the testicular weight of EES~G~ (*P*-value \<0.05) and EES + VC~G~ (*P*-value \<0.01) was found to be significantly higher than that of the control \[[Table 1](#T0001){ref-type="table"}\].

Sperm count (SC), life-death ratio (LDR) of sperm cells, sperm motility (SM), sperm morphology (SMP), and serum testosterone level (STL) {#sec2-5}
----------------------------------------------------------------------------------------------------------------------------------------

SC for EES~G~ and EES + VC~G~ treated animals was significantly (*P*-value \<0.01) higher than that of the control, whereas SC for VC~G~ alone showed no significant difference (*P*-value \>0.05) from that of the control. Likewise, LDR of EES~G~ and EES + VC~G~ was found to be significantly (*P*-value \<0.01) higher than that of the control, while VC showed no significant (*P*-value \>0.05) difference from the control \[[Table 2](#T0002){ref-type="table"}\].

###### 

Sperm count, life-death ratio of sperm cells, sperm motility, sperm morphology, and serum testosterone level

                                        Control         EES~G~                                              VC~G~                                            EES + VC~G~
  ------------------------------------- --------------- --------------------------------------------------- ------------------------------------------------ ---------------------------------------------------
  Sperm count (million cells/mm^3^)     98.1 ± 0.247    119.7 ± 0.296[\*\*](#T000F4){ref-type="table-fn"}   105.3 ± 0.349                                    129.5 ± 0.290[\*\*](#T000F4){ref-type="table-fn"}
  Life-death ratio of sperm cells (%)   4.03 ± 0.081    4.89 ± 0.077[\*\*](#T000F4){ref-type="table-fn"}    4.18 ± 0.070                                     5.16 ± 0.083[\*\*](#T000F4){ref-type="table-fn"}
  Sperm motility (%)                    79.5 ± 0.333    89.6 ± 0.244[\*](#T000F3){ref-type="table-fn"}      84.0 ± 0.295                                     91.0 ± 0.280[\*\*](#T000F4){ref-type="table-fn"}
  Sperm morphology (%)                  78.2 ± 0.303    81.5 ± 0.292                                        76.5 ± 0.241                                     84.5 ± 0.299
  Serum testosterone level (ng/ml)      21.34 ± 0.212   24.9 ± 0.195[\*](#T000F3){ref-type="table-fn"}      24.8 ± 0.158[\*](#T000F3){ref-type="table-fn"}   25.1 ± 0.142[\*](#T000F3){ref-type="table-fn"}

*P* \> 0.05

*P* \< 0.01

EES~G~ and EES + VC~G~ groups had SM that was significantly (*P*-value \<0.05 and \<0.01, respectively) higher than that of the control, whereas SM for VC~G~ was not significantly (*P*-value \>0.05) different from that of the control. SMP was, however, not significantly (*P*-value \>0.01) different in all the test groups compared with the control \[[Table 2](#T0002){ref-type="table"}\].

There was significant (*P*-value \<0.05) increase in STL in all the test groups compared to the control \[[Table 2](#T0002){ref-type="table"}\].

Plasma and testicular superoxide dismutase activity {#sec2-6}
---------------------------------------------------

Plasma and testicular SOD activity were found to be significantly higher in all the treated groups (*P*-value \<0.01 in EES~G~ and EES + VC~G~; and *P*-value \<0.05 in VC~G~) compared to the control \[[Table 3](#T0003){ref-type="table"}\].

###### 

Plasma and testicular superoxide dismutase activity

                            Control         EES~G~                                              VC~G~                                             EES + VC~G~
  ------------------------- --------------- --------------------------------------------------- ------------------------------------------------- ---------------------------------------------------
  Plasma SOD activity       1.643 ± 0.040   1.837 ± 0.037[\*\*](#T000F6){ref-type="table-fn"}   1.762 ± 0.031[\*](#T000F5){ref-type="table-fn"}   1.884 ± 0.043[\*\*](#T000F6){ref-type="table-fn"}
  Testicular SOD activity   1.602 ± 0.048   1.815 ± 0.033[\*\*](#T000F6){ref-type="table-fn"}   1.781 ± 0.045[\*](#T000F5){ref-type="table-fn"}   1.896 ± 0.051[\*\*](#T000F6){ref-type="table-fn"}

*P* \< 0.05

*P* \< 0.01

Plasma and testicular catalase activity {#sec2-7}
---------------------------------------

While testicular catalase (CAT) activity was found to be significantly higher in all the treated groups (*P*-value \<0.05) compared to the control, plasma CAT activity was only significantly (*P*-value \<0.05) higher in EES + VC~G~ \[[Table 4](#T0004){ref-type="table"}\].

###### 

Plasma and testicular catalase activity across the groups

                            Control         EES~G~                                            VC~G~                                             EES + VC~G~
  ------------------------- --------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Plasma CAT activity       0.484 ± 0.045   0.568 ± 0.039                                     0.576 ± 0.043                                     0.670 ± 0.037[\*](#T000F7){ref-type="table-fn"}
  Testicular CAT activity   0.456 ± 0.040   0.607 ± 0.033[\*](#T000F7){ref-type="table-fn"}   0.604 ± 0.033[\*](#T000F7){ref-type="table-fn"}   0.671 ± 0.050[\*](#T000F7){ref-type="table-fn"}

*P* \< 0.05

Plasma and testicular malondialdehyde concentration {#sec2-8}
---------------------------------------------------

Plasma Malondialdehyde (MDA) concentration was found to be significantly lower in all the treated groups (*P*-value \<0.05 in EES~G~ and VC~G~; and *P*-value \<0.01 in EES + VC~G~) compared to the control. In a similar way, testicular MDA concentration was found to be significantly lower in all the treated groups (*P*-value \<0.05 in EES~G~; and *P*-value \<0.01 in VC~G~ and EES + VC~G~) compared to the control \[[Table 5](#T0005){ref-type="table"}\].

###### 

Plasma and testicular malondialdehyde concentration across the groups

                                                Control          EES~G~                                             VC~G~                                               EES + VC~G~
  --------------------------------------------- ---------------- -------------------------------------------------- --------------------------------------------------- ---------------------------------------------------
  Plasma MDA concentration (μg/g protein)       1359.9 ± 1.202   1160.0 ± 1.428[\*](#T000F8){ref-type="table-fn"}   1181.1 ± 1.387[\*](#T000F8){ref-type="table-fn"}    1042.1 ± 1.34[\*\*](#T000F9){ref-type="table-fn"}
  Testicular MDA concentration (μg/g protein)   1320.6 ± 0.861   1170.5 ± 1.474[\*](#T000F8){ref-type="table-fn"}   1170.0 ± 1.28[\*\*](#T000F9){ref-type="table-fn"}   1010.0 ± 1.53[\*\*](#T000F9){ref-type="table-fn"}

*P* \< 0.05

*P* \< 0.01

DISCUSSION {#sec1-4}
==========

Even though VC is very important for normal health condition by its antioxidant and detoxification actions,\[[@CIT6]\] VC all by itself does not significantly affect the increase in body weight (weight gain). This explains the nonsignificant increase in weight gain of VC~G~ compared to the control \[[Table 1](#T0001){ref-type="table"}\]. This is in support of the findings of Ping-Chi *et al*.\[[@CIT10]\] On the contrary, EES acting alone (EES~G~) and in conjunction with VC (EES + VC~G~) significantly increases weight gain. The significant increase in weight gain in EES~G~ can be linked to the high fat composition\[[@CIT11]\] and its high caloric content. Similar findings have earlier being documented by Salawu *et al*.\[[@CIT12]\] that methanolic extract of sesame has the ability to annul the weight reducing effect of hexane extract of Jatropha curcus seed oil; Ukwenya *et al*.\[[@CIT13]\] that *Sesamum indicum* significantly improved weight gain; and by Hanefy *et al*.\[[@CIT14]\] that methanolic extract of sesame (MES) prevents protein energy malnutrition, thus improving the growth performance in animals. However, the significantly higher weight gain noticed in EES + VC~G~ reveals the possibility that EES in conjunction with VC have a synergistic effect on body weight, after all VC acting alone does not significantly affect body weight \[[Table 1](#T0001){ref-type="table"}\]. A completely similar trend to that of body weight was noticed for absolute testicular weight throughout the groups.

The observed ability of VC to increase SC \[[Table 2](#T0002){ref-type="table"}\] is in line with the outcomes of the study by Comhaire *et al*.\[[@CIT15]\] that antioxidants increase sperm concentration, and goes along with Sikka *et al*.\[[@CIT16]\] that a balance of the benefits and risks from ROS and antioxidants appears to be necessary for the survival and functioning of spermatozoa. This spermatogenic effect of VC can easily be linked to its antioxidant effects, which have been scientifically proved to be cytoprotective, and to attenuate testicular toxicity. They preserve the existing, and even make available more active/functional, semineferous tubules with good cyto-architecture. In a similar way, but with more effect, EES significantly increased SC \[[Table 2](#T0002){ref-type="table"}\]. Salawu *et al*.\[[@CIT12]\] earlier documented a similar finding on methanolic extract of sesame. The SC-increasing effect of EES + VC was more marked and seems to be additive rather than synergistic as in the case of BW. This finding is able to provide some basis for the use of sesame in addition to citrus fruits for profertility effects and for preventing infertility by the traditional doctors/in folklore medicine.

The life-death ratio (LDR) of the EES + VC~G~ was far higher than the LDR of all other groups \[[Table 2](#T0002){ref-type="table"}\]. This further establishes and tends to establish the profertility effect of oral administration of EES in conjunction with VC. This outcome is justifiable by the claims in the review by Sikka *et al*.\[[@CIT16]\] that antioxidants are necessary for the survival of spermatozoa, and by the claims of folklore medicine.

The observed significant increase in SM and SMP in ESS + VC~G~ \[[Table 2](#T0002){ref-type="table"}\] further establishes the ability of EES acting in conjunction with VC to potentiate more efficient spermatogenesis and fertility. While VC acting alone did not significantly affect both SM and SMP as against the findings of Ping-Chi *et al*.\[[@CIT10]\] that VC protects spermatozoa from the loss of motility, EES all alone significantly increased both the SM and SMP, which is in support of the findings of Shittu *et al*.\[[@CIT17]\] The increment in SM and SMP in EES~G~ was, however, lower than that of EES + VC~G~ \[[Table 2](#T0002){ref-type="table"}\]. This justifies the combination of EES and VC in traditional medicine for fertility issues, since "effect of EES + VC acting together" greater than "effect of VC and/or effect of EES acting separately."

The significant increase in both plasma and testicular SOD activity \[[Table 3](#T0003){ref-type="table"}\] and CAT activity \[[Table 4](#T0004){ref-type="table"}\] in all the treated groups is in support of the antioxidant activities of vitamin C\[[@CIT6]\] and sesame.\[[@CIT5]\] These findings are further reinforced by the significantly reduced plasma and testicular MDA contraction. The MDA concentration is lowered in all the treated groups because of their increased SOD and CAT activities.

VC acting alone, EES acting alone, and VC + EES acting together significantly increased blood testosterone level. This finding is parallel to the observations of Salawu *et al*.,\[[@CIT12]\] Ukwenya *et al*.,\[[@CIT13]\] and Shittu *et al*.\[[@CIT17]\] that sesame significantly increases blood testosterone level. This finding shows that EES and VC whether acting singly or together affect the hypothalamo-pituitary-testicular axis, thus elevating blood testosterone level. Therefore, the profertility effects of EES and VC are linked to their ability to raise the blood testosterone level, and not only to their antioxidant activities. In other words, it is scientifically reasonable to attribute the profertility effects of EES and VC to both their antioxidant effects \[6 and 11, respectively\] \[Tables [3](#T0003){ref-type="table"}--[5](#T0005){ref-type="table"}\] and their testosterone level increasing effect \[12 and 6, respectively\] \[[Table 2](#T0002){ref-type="table"}\].
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